News Daily News Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds Michael O'Riordan April 25, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm Caitlin E. Cox February 26, 2025
News Conference News THT 2025 Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity Todd Neale February 12, 2025
News Daily News Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations L.A. McKeown January 31, 2025
News Features Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? Michael O'Riordan January 17, 2025
News Daily News Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review Todd Neale January 09, 2025
News Daily News Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity L.A. McKeown December 23, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Conference News AHA 2024 Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF Shelley Wood November 18, 2024
Presentation AHA 2024 Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial Presenter: Milton Packer November 16, 2024
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024